Literature DB >> 6306105

Sequential expression of T cell activation (Tac) antigen and Ia determinants on circulating human T cells after immunization with tetanus toxoid.

A Yachie, T Miyawaki, N Uwadana, S Ohzeki, N Taniguchi.   

Abstract

Recent studies have indicated that a monoclonal antibody, termed anti-Tac, may recognize the receptor sites or closely associated structures for interleukin 2 on activated human T cells. The Tac antigen, definable by anti-Tac antibody and usually found on mitogen- or alloantigen-stimulated T cells, was not expressed to any appreciable extent on normal circulating T cells. In the present study, we showed that an increase in circulating T cells expressing Tac antigen as well as Ia determinants occurred in normal individuals after immunization with tetanus toxoid. The expression of Tac antigen and Ia determinants on T cells was evaluated by the rosette method with Staphylococcal protein A-(SPA) coated bovine red blood cells (BRBC) or the indirect immunofluorescence method with monoclonal anti-Tac and anti-Ia antibodies. An increase in Tac-positive or Ia-positive T cells was more evident with the use of the rosette method with SPA-coated BRBC than with conventional immunofluorescence. The percentage of Ia-positive T cells showed a peak between 24 and 48 hr after toxoid injection, and remained at high levels until 2 wk after immunization. In contrast to Ia-positive T cells, the appearance of Tac-positive T cells was transient and at a rather early period of toxoid immunization. The maximum increase of Tac-positive T cells was apparent around 12 hr after toxoid injection, and Tac-positive T cells disappeared abruptly from circulation by 24 hr after inoculation. Ia-positive T cells were induced in both Leu-2 suppressor/cytotoxic and Leu-3 helper/inducer subsets, whereas Tac-positive T cells were generated only within the Leu-3 subset. The fact that induction of Tac-positive and Ia-positive T cells might occur at different stages of T cell activation and in different subsets of T cells seemed to be important for elucidating their roles in the in vivo T cell proliferation and differentiation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6306105

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Expression of CD45R0 (UCHL1) by CD4+ and CD8+ T cells as a sign of in vivo activation in infectious mononucleosis.

Authors:  T Miyawaki; Y Kasahara; H Kanegane; K Ohta; T Yokoi; A Yachie; N Taniguchi
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

2.  Molecular basis for two different affinity states of the interleukin 2 receptor: affinity conversion model.

Authors:  S Kondo; A Shimizu; Y Saito; M Kinoshita; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

3.  Immunoregulation in onchocerciasis. Functional and phenotypic abnormalities of lymphocyte subsets and changes with therapy.

Authors:  D O Freedman; A Lujan-Trangay; C Steel; C Gonzalez-Peralta; T B Nutman
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

4.  Interleukin 2 receptor expression by human blood lymphocytes after vaccination with pneumococcal polysaccharides.

Authors:  N Tvede; C Heilmann; L D Christensen
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

5.  IL-2 receptor and HLA class II antigens on cerebrospinal fluid cells of patients with multiple sclerosis and other neurological diseases.

Authors:  E Tournier-Lasserve; O Lyoncaen; E Roullet; M A Bach
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

6.  Activation of peripheral blood lymphocytes in patients with primary Sjögren's syndrome.

Authors:  P Youinou; Y L Pennec; M A Blaschek; A Gentric; J Jouquan; A Lamour; P Angelidis
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

7.  Antigenic stimulation regulates the level of expression of interleukin 2 receptor on human T cells.

Authors:  M E Hemler; M B Brenner; J M McLean; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

8.  Evidence of cells bearing interleukin-2 receptor at sites of disease activity in sarcoid patients.

Authors:  G Semenzato; C Agostini; L Trentin; R Zambello; M Chilosi; A Cipriani; E Ossi; M R Angi; L Morittu; G Pizzolo
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

9.  Preferential expression of IL-2 receptor subunits on memory populations within CD4+ and CD8+ T cells.

Authors:  K Taga; Y Kasahara; A Yachie; T Miyawaki; N Taniguchi
Journal:  Immunology       Date:  1991-01       Impact factor: 7.397

10.  Clinical and immunological effects of human recombinant interleukin-2 given by repetitive weekly infusion to normal dogs.

Authors:  S C Helfand; S A Soergel; P S MacWilliams; J A Hank; P M Sondel
Journal:  Cancer Immunol Immunother       Date:  1994-08       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.